Scalable rubella production in scale-X™ bioreactor with MRC-5 cells (Nov 2022)

Article

Sponsored Content

This application note demonstrates the successful transfer, optimization and scale-up of the Rubella vaccine manufacturing process from static flasks to scale-X™ bioreactors.

Related Content
© 2024 MJH Life Sciences

All rights reserved.